If any more evidence were needed of a bounceback in venture financing for biotechs after a dip in 2023, the $400 million first round just announced by Mirador Therapeutics should suffice.

Shares of Meta Platforms (NASDAQ: META) were pulling back today on a combination of a broad-based sell-off related to the upcoming "Liberation Day" round of tariffs, and as one analyst lowered its ...

A digital therapeutic (DTx) is defined as “health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that has a ...

At close: April 1 at 3:58:24 p.m. EDT ...

At close: 1 April at 3:58:24 pm GMT-4 ...

At close: April 4 at 4:00:01 PM EDT ...

Looking for a biopharma job? Check out the BioSpace list of 12 top companies hiring life sciences professionals like you. The biopharma job market fared better in March than in February, based on ...

Annalee Armstrong is an award-winning biopharma journalist covering the business of drug development. She began her career at small newspapers across Western Canada. During the assignment of a ...